Express Healthcare

HealthPlix releases ‘Prescription Summary Dashboard’ for doctors

0 617

Offers a longitudinal view of disease progression that helps doctors understand, assess & compare various treatment regimens

HealthPlix Technologies has announced the release of ”Prescription Summary Dashboard’ for doctors. The new feature release from the ROBIN suite, is an analytical software that sits on HealthPlix flagship product – EMR. With this second feature release – Prescription Summary Dashboard, doctors can analyse their historical prescriptions to identify different cohorts of patients and the treatment given to them.

Sandeep Gudibanda, CEO, HealthPlix Technologies said, “Engagement in healthcare is significantly more challenging than in other industries. Furthermore, except for healthcare, analytics has been used in a variety of businesses for the past decade or more. The ability to provide doctors with a simple visual representation of a patient’s prescription history that is backed by analytics has the potential to drive better health outcomes and transform the doctor-patient relationship. Prescriptive analytics assists the doctor in making productive decisions, as well as absorbing new information efficiently for their research needs.”

Chaitanya Raju, Chief of AI, HealthPlix Technologies added, “Currently, doctors have no way of obtaining information on the medications administered to a specific cohort of patients. It is a time-consuming process with the potential for misinterpretation. The prescription summary dashboard is a one-click deep dive analysis tool for doctors making patient care more efficient. It is consistent with our mission to provide doctors with solutions that will help them save time, provide superior care, and improve the in-clinic experience.”

The health-tech start-up is backed by marquee investors such as Lightspeed Venture Partners, JSW Ventures, Kalaari Capital and Chiratae Ventures. In their latest round of funding, HealthPlix raised $13.5 million as part of Series B funding, which was led by Lightspeed Ventures and joined by existing investors.

- Advertisement -

Leave A Reply

Your email address will not be published.